Insiders Denali Therapeutics Inc.

Equities

DNLI

US24823R1059

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-05-13 pm EDT			5-day change	1st Jan Change
19.80 ^USD	+1.75%		-2.99%	+19.93%

May. 08	Wedbush Adjusts Denali Therapeutics Price Target to $23 From $25, Maintains Outperform Rating	MT
May. 07	Denali Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Insiders

Nov. 06	Denali Therapeutics Inc. Announces Board and Executive Changes	CI
25-07-11	Denali Therapeutics Insider Sold Shares Worth $7,429,230, According to a Recent SEC Filing	MT
25-06-03	Denali Therapeutics Inc. Elects Julian Baker as Class II Director	CI
24-11-13	Denali Therapeutics Insider Sold Shares Worth $1,932,665, According to a Recent SEC Filing	MT
24-10-22	Denali Therapeutics Insider Sold Shares Worth $1,107,600, According to a Recent SEC Filing	MT
24-08-22	Denali Therapeutics Insider Sold Shares Worth $549,928, According to a Recent SEC Filing	MT
24-04-03	Denali Therapeutics Insider Sold Shares Worth $1,896,250, According to a Recent SEC Filing	MT
24-02-16	Denali Therapeutics Insider Sold Shares Worth $402,420, According to a Recent SEC Filing	MT
23-07-19	Insider Sell: Denali Therapeutics	MT
23-05-17	Insider Sell: Denali Therapeutics	MT
23-02-16	Insider Sell: Denali Therapeutics	MT
23-02-14	Insider Sell: Denali Therapeutics	MT
22-11-03	Insider Sell: Denali Therapeutics	MT
22-09-30	Insider Sell: Denali Therapeutics	MT
22-03-15	Denali Therapeutics COO to Add CFO Duties; Current CFO to Join Board	MT
22-03-15	Denali Therapeutics Inc. Appoints Steve Krognes to Board of Directors	CI
22-02-07	Denali Therapeutics Announces Appointment of Erik Harris to Board of Directors	CI
21-11-03	Insider Sell: Denali Therapeutics	MT
21-10-05	Insider Sell: Denali Therapeutics	MT
21-09-27	Denali Therapeutics Inc Appoints Katie Peng as Chief Commercial Officer	CI
21-09-09	Insider Sell: Denali Therapeutics	MT
21-09-03	Insider Sell: Denali Therapeutics	MT
21-08-06	Insider Trends: Denali Therapeutics Insider Continues 90-Day Selling Trend	MT
21-08-04	Insider Trends: Denali Therapeutics Insider Extends 90-Day Selling Trend	MT
21-07-23	Insider Trends: Denali Therapeutics Insider Extends 90-Day Selling Trend	MT